If ischemic preconditioning is the gold standard, has a platinum standard of cardioprotection arrived? Comparison with NHE inhibition

Journal of Thrombosis and Thrombolysis

Volumn 8, Issue 1, 1999, Pages 39-44

  Gumina, Richard J ^a   Gross, Garrett J ^b  

^a MAYO CLINIC   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Ischemic preconditioning; Myocardial infarction; Sodium hydrogen exchange

Indexed keywords

AMILORIDE DERIVATIVE; CARIPORIDE; CARRIER PROTEIN; POTASSIUM CHANNEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; DOG; ENZYME INHIBITION; HEART INFARCTION PREVENTION; HEART MUSCLE ISCHEMIA; HEART PROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTON SODIUM EXCHANGE; RABBIT; RAT; REVIEW;

ANIMALS; HUMANS; ISCHEMIC PRECONDITIONING; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; SODIUM-HYDROGEN ANTIPORTER;

EID: 0032789045     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008942614246     Document Type: Review

References (37)

1. Murry C, Jennings R, Reimer K. Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium. Circulation 1986;74:1124-1136.
2. Meldrum D. Mechanisms of cardiac preconditioning: Ten years after the discovery of ischemic preconditioning. J Surgi Res 1997;73:1-13.
3. Gross G, Auchampach J. Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs. Circ Res 1992;70:223-233.
4. ATP channels and ischemic preconditioning. Am J Physiol 1993;264:H1327-H1336.
5. Ytrehus K, Liu Y, Downey L. Preconditioning protects ischemic rabbit heart by protein kinase C activation. Am J Physiol 1994;266:H1145-H1152.
6. Maulik N, Watanabe M, Zu Y-L, Huang C-K, Cordis G, Schley J, Das D. Ischemic preconditioning triggers the activation of MAP kinases and MAPKAP kinase 2 in rat hearts. FEBS Lett 1996;396:233-237.
7. Vahlhaus C, Schulz R, Post H, Rose J, Heusch G. Prevention of ischemic preconditioning only by combined inhibition of protein kinase C and tyrosine kinase in pigs. J Mol Cell Cardiol 1998;30:197-209.
8. Karmazyn M. The sodium-hydrogen exchange system in the heart: Its role in ischemic and reperfusion injury and therapeutic implications. Can J Cardiol 1996;12:1074-1082.
9. + exchanger NHE-1 and two structurally related proteins. J Biol Chem 1992;267:9331-9339.
10. Murry C, Richard V, Reimer K, Jennings R. Ischemic preconditioning slows energy metabolism and delays ultrastructural damage during a sustained ischemic episode. Circ Res 1990;66:913-931.
11. Kida M, Fujiwara H, Ishida M, Kawai C, Ohura M, Miura I, Yabuuchi Y. Ischemic preconditioning preserves creatine phosphate and intracellular pH. Circulation 1991;84: 2495-2503.
12. Asimakis G, Inners-McBride K, Medellin G, Conti V. Ischemic preconditioning attenuates acidosis and postischemic dysfunction in isolated rat heart. Am J Physiol 1992;263:H887-H894.
13. Wolfe C, Sievers R, Visseren F, Donnelly T. Loss of myocardial protection after preconditioning correlates with the time course of glycogen recovery within the preconditioned segment. Circulation 1993;87:881-892.
14. Steenbergen C, Perlman M, London R, Murphy E. Mechanism of preconditioning: Ionic alterations. Circ Res 1993;72: 112-125.
15. Ramasamy R, Liu H, Anderson S, Lundmark J, Schaefer S. Ischemic preconditioning stimulates sodium and proton transport in isolated rat hearts. J Clin Invest 1995;96: 1464-1472.
16. + concentration. A molecular basis for the antagonistic effect of ouabain and amiloride on the heart. J Biol Chem 1984;259:8880-8885.
17. Lazdunski M, Frelin C, Vigne P. The sodium/hydrogen exchange system in cardiac cells: Its biochemical and pharmacological properties and its role in regulating internal concentrations of sodium and internal pH. J Mol Cell Cardiol 1985;17:1029-1042.
18. Poole-Wilson P. Regulation of intracellular pH in the myocardium; relavance to pathology. Mol Cell Biochem 1989;89: 151-155.
19. 2+ exchange. Circ Res 1989;65:1045-1056.
20. duToit E, Opie L. Modulation of severity of reperfusion stunning in the isolated rat heart by agents altering calcium flux at onset of reperfusion. Circ Res 1992;70:960-967.
21. Wilde A, Janse M. Electrophysiological effects of ATP sensitive potassium channel modulation: Implications for arrhythmogenesis. Cardiovasc Res 1994;28:16-24.
22. 2+ as a mediator of ischemic preconditioning. Circ Res 1997:790.
23. Auchampach J, Maruyama M, Cavero I, Gross G. Pharmacological evidence for a role of ATP-dependent potassium channels in myocardial stunning. Circulation 1992;86: 311-319.
24. Steenbergen C, Perlman M, London R, Murphy E. Correlation between cytosolic free calcium, contracture, ATP, and irreversible ischemic injury in perfused rat heart. Circ Res 1990;66:135-146.
25. Mizumura T, Gross G, Schultz J. A new sodium-hydrogen exchange (NHE) inhibitor, EMD 85131, limits infarct size (IS) in dogs independent of adenosine (Ado) or ATP-sensitive potassium (KATP) channels. Circulation 1997;00(Suppl. I):I140.
26. Sato H, Miki T, Vallabhapurapu R, Wang P, Liu G-S, Cohen M, Downey J. The mechanism of protection from 5 (N-ethyl-N-isopropyl)amiloride differs from that of ischemic preconditioning in rabbit heart. Basic Res Cardiol 1997;92: 339-350.
27. + exchange inhibitor, Hoe 642: Difference from preconditioning in the role of protein kinase C. J Am Coll Cardiol 1997;29:693-701.
28. Gross G, Schultz J. In dogs tolerant to ischemic preconditioning (IPC), the sodium-hydrogen exchange (NHE) inhibitor, EMD 85131 retains its efficacy to reduce myocardial infarct size (IS). Circulation 1997;00(Suppl. I):I743.
29. Przyklenk K, Hata K, Kloner R. Is calcium a mediator of infarct size reduction with preconditioning in canine myocardium. Circulation 1997;96:1305-1312.
30. Kleyman T, Cragoe E. Amiloride and its analogs as tools in the study of ion transport. J Membr Biol 1988;105:1-21.
31. Pierce G, Cole W, Liu L, et al. Modulation of cardiac performance by amiloride and several selected derivatives of amiloride. J Pharmacol Exp Ther 1993;265:1280-1291.
32. Bugge E, Ytrehus K. Inhibition of sodium-hydrogen exchange reduces infarct size in the isolated rat heart - a protective additive to ischemic preconditioning. Cardiovasc Res 1995;29:269-274.
33. + exchanger activity does not contribute to protection by ischemic preconditioning in the isolated rat heart. Circulation 1997;96:3617-3625.
34. + exchanger: Greater efficacy against 90 minutes of myocardial ischemia than ischemic preconditioning in dogs. Circulation 1999, in press.
35. Nao B, McClanahan T, Groh M, Schott R, Gallagher K. The time limit of effective ischemic preconditioning in dogs (abstr). Circulation 1990;82(Suppl. III):III271.
36. + exchange inhibitor reduces infarct size in pigs. Cardiovasc Res 1995;30: 945-951.
37. + exchange (NHE-1) inhibitor, EMD 85131, limits infarct size in dogs when administered prior to or after coronary artery occlusion. J Pharmacol Exp Ther 1998;286:175-183.